Piramal Pharma Solutions has completed an expansion at its Michigan site where it makes high-potency active pharmaceutical ingredients (HPAPIs). The company has intensified its focus on the US market including buying an API producer in Michigan several years ago.

The company invested $10 million in the former Ash Stevens site in Riverview, Michigan, where it makes HPAPis with low exposure levels, adding two-kilo labs as well as quality control and analysis labs. It is now capable of making HPAPIs with OELs down to 1mcg/m3.  

It has added nearly 50 jobs. It has 127 workers now but says it plans to soon have 150. 

Piramal bought the Ash Stevens operations in 2016 for $53 million.